Navigation Links
Shimadzu's New DSC-60 Plus Series Differential Scanning Calorimeters Offer High-Sensitivity Analysis in Polymer, Food and Pharmaceutical Applications
Date:4/18/2013

Columbia, Maryland (PRWEB) April 18, 2013

Shimadzu Scientific Instruments has introduced the DSC-60 Plus Series differential scanning calorimeters, indispensable thermal analyzers for materials characterization. The DSC-60 Plus Series offers the high-sensitivity analysis and easy operation required for the development of high-functioning new materials in the food, polymer and pharmaceutical industries.

As high-performance, general-purpose differential scanning calorimeters, the DSC-60 Plus Series offers high sensitivity and high resolution during analysis. Its new detector and unique furnace construction achieve a stable baseline across the entire measured temperature range (-140 to 600° C), as well as top-class temperature sensitivity. The eco-friendly furnace achieves more than 20 percent lower energy consumption when heating from room temperature.

A cooling chamber comes installed as standard on the DSC-60 Plus Series. The liquid-nitrogen cooling chamber permits easy measurements without the need for special accessories. Further, it achieves a cooling rate of 10° C/minute at -100° C. Its sample loading temperature function enables quick sample change without dewfall during sequential analysis.

The DSC-60A Plus model features a built-in compact autosampler, which permits automated measurement, analysis and report printout for up to 24 loaded samples. It improves the efficiency of screening during product development, as well as the efficiency of quality control activities.

Additionally, the DSC-60 Plus Series complies with various analytical laboratory regulations, including the U.S. Food and Drug Administration’s 21 CFR Part 11.

For more information about the DSC-60 Plus Series, visit http://www.ssi.shimadzu.com/products/product.cfm?product=dsc60Plus.

About Shimadzu Scientific Instruments Inc.
Shimadzu Scientific Instruments (SSI) is the American subsidiary of Shimadzu Corp., headquartered in Kyoto, Japan. Founded in 1875, Shimadzu is a $3 billion multinational corporation with three major divisions: Medical Diagnostics, Aerospace/Industrial and Analytical Instruments. In the United States, SSI has a network of more than 50 locations providing local and regional sales, service and technical support. Visit http://www.ssi.shimadzu.com for more information.

###

Read the full story at http://www.prweb.com/releases/2013/4/prweb10650226.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Avaxia Biologics, Inc. Raises $2.2 Million in First Closing of Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease
2. Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising
3. InnoPharma Completes $15 Million Series A Financing
4. Aratana Therapeutics Completes $15 Million Series B Financing
5. PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
6. Roka Bioscience Secures $47.5 Million in Series D Financing
7. Auxogyn Completes $20 Million In Series A Funding
8. Avaxia Biologics, Inc. Closes $4.1 Million Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease
9. NeuroPhage Extends Series B to $21.4M
10. Tarsa Therapeutics Completes $28 Million Series B Financing to Advance OSTORA™ Oral Calcitonin
11. Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... February 12, 2016 , ... The Pittcon 2016 Exposition, which ... will include 848 exhibitors (count as of February 9) of which 119 are ... used by the scientific community in industrial, academic, and government labs. The Exposition ...
(Date:2/12/2016)... FRANCISCO , February 12, 2016 ... Medicine Efforts by Enabling Scientific Understanding of Complex ... and Rare Diseases --> ... genomic diagnostics in South Asia and a leading provider ... would contribute $10 million to the GenomeAsia 100K ...
(Date:2/11/2016)... 2016  Vermillion, Inc. (NASDAQ: VRML ), a ... the formation of the Steering Committee for its Pelvic ... --> Pelvic masses can present physicians and healthcare ... pregnancy is ruled out, pelvic masses may include cancers ... benign ovarian tumors and gastrointestinal and urinary tract masses. ...
(Date:2/11/2016)... Feb. 11, 2016  Spectra BioPharma Selling Solutions (Spectra) ... provides biopharma companies the experience, expertise, operational delivery ... outsourced sales teams. Created in concert with industry ... the strategic and tactical needs of its clients ... through both personal and non-personal promotion. ...
Breaking Biology Technology:
(Date:1/22/2016)... DUBLIN , January 22, 2016 ... has announced the addition of the  ... to their offering. --> ... of the  "Global Behavioral Biometric Market ... --> Research and Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ...
(Date:1/20/2016)... Jan. 20, 2016 A market that just ... benefit from the explosion in genomics knowledge. Learn all ... Research. A range of dynamic trends are pushing market ... personalized medicine - pharmacogenomics - pathogen evolution - next ... markets - greater understanding of the role of genetic ...
(Date:1/18/2016)... , Jan. 18, 2016  Extenua Inc., ... that simplifies the use and access of ubiquitous ... go-to-market partnership with American Cyber.  ... extensive experience leading transformational C4ISR and Cyber initiatives ... integrating the latest proven technology solutions," said ...
Breaking Biology News(10 mins):